Pete Pharma and FABRX announce strategic partnership
Pete Pharma will leverage FABRX’s extensive foundation of scientific validation to deliver a commercially viable, pharmacy-ready solution in the US
Pete Pharma will leverage FABRX’s extensive foundation of scientific validation to deliver a commercially viable, pharmacy-ready solution in the US
Products manufactured at the new Vaughan facility will support research in areas including cancer, infectious disease, mental health, and environmental safety
The facility has been designed with a dual focus on efficiency and sustainability
Agreement further expands Aptar Pharma’s leading position in nasal delivery solutions and addresses significant unmet needs of delivering drugs locally over extended periods
New manufacturing facility in Mebane to produce at least 40 million laboratory pipette tips per week
The company is bringing precision therapies for gynaecological cancers
This acquisition expands HGM's healthcare platform capabilities in revenue cycle management
A global platform advancing pharmaceutical collaboration, innovation, and exports—powering healthcare and connecting markets worldwide
Shelcal Total marks the brand’s evolution into a modern, consumer-focused nutrition portfolio
The campaign celebrates radiant, healthy skin that shines naturally, empowering women to step forward with confidence in every walk of life.
Subscribe To Our Newsletter & Stay Updated